Volume 95 Issue 20 | p. 18 | Concentrates
Issue Date: May 15, 2017

DSM and Amyris pursue vitamin A

Department: Business
Keywords: biobased chemicals, nutrition, vitamins, rubber

DSM will invest $25 million in the biobased chemicals maker Amyris and may follow with another $25 million. At the same time, the two firms will work on health-related products. They have an exclusive agreement to develop a fermentation route to vitamin A, which is normally made via chemical synthesis. If DSM does invest the full $50 million, it will own almost one-quarter of Amyris. Other, unnamed investors have committed an additional $45 million. Amyris . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society